BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $175,500 | -66.9% | 97,500 | -68.9% | 0.05% | -65.7% |
Q3 2022 | $530,000 | -31.3% | 313,600 | 0.0% | 0.14% | -31.9% |
Q2 2022 | $771,000 | -11.3% | 313,600 | 0.0% | 0.21% | -7.1% |
Q1 2022 | $869,000 | -20.9% | 313,600 | +52.2% | 0.23% | -18.1% |
Q4 2021 | $1,099,000 | – | 206,100 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $8,487,000 | 0.44% |
Hawkeye Capital Management, LLC | 243,009 | $598,000 | 0.33% |
Boxer Capital, LLC | 2,014,858 | $4,957,000 | 0.31% |
Newtyn Management, LLC | 520,000 | $1,279,000 | 0.24% |
Artal Group S.A. | 1,646,517 | $4,050,000 | 0.22% |
DAFNA Capital Management LLC | 313,600 | $771,000 | 0.21% |
RA Capital Management | 2,589,904 | $6,371,000 | 0.17% |
Bellevue Group AG | 4,717,113 | $11,605,000 | 0.16% |
MPM BioImpact LLC | 239,888 | $590,000 | 0.16% |
K2 PRINCIPAL FUND, L.P. | 507,652 | $1,249,000 | 0.14% |